232 results on '"Jalan, R."'
Search Results
2. Anti-Inflammatory Activity of Boerhavia diffusa Zinc Oxide Nanoparticle
3. SIRS, Bacterial Infections, and Alterations of the Immune System
4. Molecular Adsorbents Recirculating System (MARS) for acute decompensation of chronic liver disease: an early clinical experience
5. Hypothermia for the management of intracranial hypertension in acute liver failure
6. Metabolic consequences of an upper gastro-intestinal bleed in patients with cirrhosis
7. Increased cerebral and peripheral vasodilation, and whole body nitric oxide production after insertion of a transjugular intrahepatic portal-systemic stent in patients with cirrhosis
8. P: 44 Non-canonical Inflammasome as a Driver of Hepatic Encephalopathy in a Mouse Model of Acute-on-Chronic Liver Failure
9. Der relative Körperfettgehalt ist bei Patienten mit Leberzirrhose mit dem Auftreten von Tod und Komplikationen zur Lebertransplantation assoziiert
10. Rekombinante Alkalische Phosphatase ist eine neue Therapieoption zur Prävention des akut-auf-chronischen Leberversagens aber nicht des akuten Leberversagens
11. Role of Toll-like receptor 4 (TLR4) in regulating severity of hyperammonemia and gene expression of urea cycle enzymes
12. Ammonia: A novel target for the prevention of NAFLD progression in NASH
13. Class III (morbid) obesity is an independent risk factor for the development of acute on chronic liver failure in patients with decompensated cirrhosis
14. The physical component of the SF-36 Quality of Life tool is an independent predictor of mortality in patients with severe ascites
15. Combinations of inflammatory markers, soluble (s)CD163, mannose receptor (sMR) and neutrophil gelatinase associated lipocalin (NGAL), predicts mortality in patients with acute-on-chronic liver failure
16. Treatment with the Adra2a antagonist, Yohimbine, reduces fibrosis progression and liver inflammation in a NASH fibrosis rat
17. Epigenetic modification of urea cycle enzymes in NAFLD animal models and patients: Implications for novel therapeutic approaches
18. Acute-on-chronic liver failure is characterised by hepatocyte gasdermin D cleavage and release of the pro-inflammatory Damage Associated Molecular Pattern (DAMP) IL-α
19. Characterization of the protective effects of yaq-001on organ injury in cirrhosis
20. Acute Liver Failure-Organ Failure (ALF-OF) score is better than King’s College Hospital criteria in predicting mortality in patients with non-paracetamol-related acute liver failure (ALF)
21. The kynurenine pathway in cirrhosis. Relationship with the development of acute decompensation and acute-on-chronic liver failure, clinical course and mortality
22. Impact of receptor interacting protein kinase 3 levels on acute on chronic liver failure progression
23. Neurocognitive dysfunction in NAFLD occurs early and is associated with hyperammonemia, neurotransmitter defects, astroglial and microglial activation
24. Post-Transcriptional Regulation of Hepatic DDAH1 with TNF Blockade Leads to Improved eNOS Function and Reduced Portal Pressure In Cirrhotic Rats
25. Editorial: proton pump inhibitor therapy and liver disease progression-more cause for concern?
26. Editorial: alfapump—an alternative to large‐volume paracentesis for patients with refractory ascites?
27. Porto- systemic shunt embolization and recurrent ascites:a single centre case series
28. Evaluation of the CLIF-C ACLF score in critically ill cirrhotic patients in intensive care units in Europe and North America: a multicenter cohort study
29. Early increase in ammonia is a feature of non-alcoholic fatty liver disease and the ammonia lowering drug, ornithine phenylacetate (OCR-002) prevents progression of fibrosis in a rodent model
30. Cirrhosis and acute on chronic liver failure: is ammonia a predictor of hepatic encephalopathy and mortality?
31. Systemic delivery of gene therapy – a proof of concept study in a model of cirrhosis and portal hypertension
32. Ammonia elevates B-neurexin in hepatic stellate cells to escape NK cells activity
33. Neutrophil dysfunction is potentially predictive of mortality and multi-organ failure in acute decompensation and acute-on-chronic liver failure patients
34. Prolonged intensive care support of patients with acute on chronic liver failure and CLIF-C ACLF score greater than 70 may be futile
35. Impaired cerebral oxygenation, but preserved cerebrovascular reactivity, in an animal model of hepatic encephalopathy
36. Human Serum Albumin administration prevents cell death-derived extracellular nucleosomes and core-histones-driven inflammasome activation and portal hypertension in Acute on Chronic Liver Failure
37. Monocytes exhibit an immune and metabolic reprogramming during acute-on-chronic-liver-failure
38. Brain glymphatic clearance is impaired in a rat model of cirrhosis
39. DASIMAR: a novel prognostic biomarker for acute cirrhosis decompensation to guide early intervention - a prospective multicenter study
40. Bacterial and fungal infections in acute-on-chronic liver failure: prevalence, characteristics and impact on prognosis
41. Neurobehavioral disturbances and hyperammonemia are evident in rodent model of NAFLD prior to cirrhosis stages
42. Neutrophil gelatinase-associated lipocalin is a biomarker of acute-on-chronic liver failure and prognosis in cirrhosis
43. PTU-090 Circulating Level of End Product of Apoptosis Caspase-Cleaved Keratin 18 Reflects Clinical Severity in Acute on Chronic Liver Disease and Is A Potential Biomarker for Diagnosis and Therapeutic Monitoring
44. Early invasive fungal infections and colonization in patients with cirrhosis admitted to the intensive care unit
45. The TLR10 polymorphism rs4129009 is associated to poor 28-day survival in patients with cirrhosis and acute on chronic liver failure precipitated by bacterial infection
46. TLR-10 Single Nucleotide Polymorphism is Associated to Poor Short Term Survival in Cirrhotic Patients with Acute on Chronic Liver Failure Precipitated by Bacterial Infections
47. Soluble CD163, a Marker of Macrophage Activation, is Increased in Early Allograft Dysfunction after Liver Transplantation
48. Clif-C ALF Score is a New Prognostic Tool to Identify Liver Transplant Candidates in Patients with Paracetamol Related Acute Liver Failure and it can Predict the Futility of Liver Transplantation
49. Alterations in the CNS Hemichannel Function and Neurochemical Phenotype in the Pathogenesis of Hepatic Encephalopathy
50. Noradrenaline Potentiates Portal Hypertension through the Alpha 2a Adrenergic Receptor – A target for Therapy in Portal Hypertension
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.